[Sevoflurane and liver dysfunction].
Fernández-Meré
L A
LA
Muñoz González
F
F
Sopena Zubiria
L A
LA
Alvarez Blanco
M
M
D000410:Alanine Transaminase / Q000097:blood; D018685:Anesthetics, Inhalation / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D001219:Aspartate Aminotransferases / Q000097:blood; D019928:Breast Implantation; D001943:Breast Neoplasms / Q000601:surgery; D056486:Chemical and Drug Induced Liver Injury / Q000097:blood / Q000209:etiology*; D000075202:Contraindications; D005260:Female; D006801:Humans; D008102:Liver Circulation / Q000187:drug effects; D008408:Mastectomy; D008738:Methyl Ethers / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D008875:Middle Aged; D012008:Recurrence; D000077149:Sevoflurane; D005723:gamma-Glutamyltransferase / Q000097:blood
D018685:Anesthetics, Inhalation; D008738:Methyl Ethers; D000077149:Sevoflurane; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase